Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Lab Invest. 2011 Feb 21;91(5):732–743. doi: 10.1038/labinvest.2011.8

Table 1.

V-ATPase immuno-labeling demonstrates a progressive increase in intensity and loss of polarity from early PanIN lesions to pancreatic ductal adenocarcinoma (PDAC). Immunohistochemical staining of v-ATPase was graded by two independent pathologists based on intensity (upper panel) and distribution within the cells (lower panel) in randomly selected fields. The intensity score for normal ducts (1.24±0.43), low grade PanINs (1.72±0.45), high grade PanINs (2.56±0.50) and PDAC (all 3+) were significantly different among the groups, P<0.001. While the majority of normal pancreatic ducts showed a faint mixed basal/apical v-ATPase pattern, low grade PanINs mostly (86%) had a basal v-ATPase distribution within cells. The majority (94%) of high grade PanINs and all the PDAC had a diffuse distribution of v-ATPase compared to low grade PanIN lesions, P<0.001.

Histology 1+ 2+ 3+ Intensity score (mean ± SD)
Normal ducts 38/50 (76) 12/50 (24) 0/50 1.24 ± 0.43
Low grade PanIN 14/50 (28) 36/50 (72) 0/50 1.72 ± 0.45
High grade PanIN 0/50 22/50 (44) 28/50 (56) 2.56 ± 0.50
PDAC 0/50 0/50 50/50 (100) 3.00 ±0.00
Histology Basal Mixed basal/apical Diffuse
Normal ducts 0/50 50/50 (100) 0/50
Low grade PanIN 43/50 (86) 5/50 (10) 2/50(4)
High grade PanIN 3/50(6) 0/50 47/50 (94)
PDAC 0/50 0/50 50/50 (100)